Evercore ISI restated their buy rating on shares of Imperva Inc (NYSE:IMPV) in a research report sent to investors on Wednesday morning. They currently have a $56.00 price target on the software maker’s stock.

IMPV has been the subject of a number of other reports. Piper Jaffray Companies reaffirmed a neutral rating and issued a $58.00 target price on shares of Imperva in a research note on Friday, October 13th. BidaskClub raised shares of Imperva from a sell rating to a hold rating in a research note on Tuesday, September 12th. Stifel Nicolaus reaffirmed a hold rating and issued a $47.00 target price on shares of Imperva in a research note on Friday, July 14th. KeyCorp reaffirmed a hold rating on shares of Imperva in a research note on Tuesday, October 24th. Finally, William Blair downgraded shares of Imperva from an outperform rating to a market perform rating in a research note on Tuesday, October 10th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Imperva presently has an average rating of Hold and a consensus target price of $52.38.

Imperva (IMPV) opened at $41.20 on Wednesday. Imperva has a 12 month low of $35.45 and a 12 month high of $52.40.

Imperva (NYSE:IMPV) last announced its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. During the same period in the previous year, the firm posted $0.08 earnings per share. The company’s revenue was up 22.6% on a year-over-year basis.

WARNING: “Imperva Inc (IMPV) Receives “Buy” Rating from Evercore ISI” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.watchlistnews.com/imperva-inc-impv-receives-buy-rating-from-evercore-isi/1697205.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the transaction, the director now owns 99,598 shares in the company, valued at $4,341,476.82. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.20% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. grew its holdings in Imperva by 18.7% during the second quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares during the period. SG Americas Securities LLC acquired a new position in shares of Imperva in the third quarter valued at approximately $134,000. First Quadrant L P CA acquired a new position in shares of Imperva in the third quarter valued at approximately $136,000. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in shares of Imperva by 26.2% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after buying an additional 866 shares during the period. Finally, Amalgamated Bank acquired a new position in shares of Imperva in the second quarter valued at approximately $206,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.